文献

DEXPAT（製品コード 9091）Citations

• J Clin Microbiol. 2006 ;44(2):612-3.
  Chedore P, et al.
  False-positive amplified Mycobacterium tuberculosis direct test results for samples containing Mycobacterium leprae.



• Clin Cancer Res. 2006 ;12(1):43-8.
  Asano H, et al.
  Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.



• Jpn J Clin Oncol. 2006 ;36(1):17-24.
  Ryu MH, et al.
  Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate.



• J Clin Microbiol. 2006 ;44(5):1859-62.
  Umeyama T, et al.
  Novel approach to designing primers for identification and distinction of the human pathogenic fungi Coccidioides immitis and Coccidioides posadasii by PCR amplification.



• Clin Cancer Res. 2006 ;12(13):3915-21.
  Kimura H, et al.
  Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.



• Jpn J Clin Oncol. 2006 ;36(8):523-6.
  Chou WC, et al.
  Different responses to gefitinib in lung adenocarcinoma coexpressing mutant- and wild-type epidermal growth factor receptor genes.



• Clin Cancer Res. 2006 ;12(20 Pt 1):6116-24.
  Yoshino T, et al.
  Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy.



• Carcinogenesis. 2005 ;26(1):229-238.
  Tanaka T, et al.
  Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess {beta}-catenin gene mutations and increases immunoreactivity for {beta}-catenin, cyclooxygenase-2 and inducible nitric oxide synthase.



• Cancer Res. 2005 ;65(5):1897-903.
  Basciani S, et al.
  Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.



• J Clin Pathol. 2005 ;58(3):334.
  Paterson PJ, et al.
  Molecular confirmation of invasive infection caused by Chaetomium globosum.



• Vet Pathol. 2005 ;42(2):176-83.
  Toyoda T, et al.
  Multiple perineuriomas in chicken (Gallus gallus domesticus).



• Clin Cancer Res. 2005 ;11(3):1167-73.
  Tokumo M, et al.
  The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.



• Ann Oncol. 2005 ;16(8):1334-42.
  Zhang XT, et al.
  The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer.



• Clin Cancer Res. 2005 ;11(11):4067-73.
  de Jong KP, et al.
  P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.



• Clin Cancer Res. 2004 ;10(24):8195-203.
  Huang SF, et al.
  High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.



• Carcinogenesis. 2004 ;25(10):1967-72.
  Kawamori T, et al.
  Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats.

TaKaRa DEXPAT
1）Goelz, S. E. et al.（1985）BBRC, 130, No. 1, 118-126.
2）佐藤雄一ら（1990）病理と臨床 (別冊), 8, 432-453.